Welcome to LookChem.com Sign In|Join Free
  • or
5-(HYDROXYMETHYL)-2-METHYL-3-FUROIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

15341-68-1

Post Buying Request

15341-68-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15341-68-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 15341-68-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,3,4 and 1 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 15341-68:
(7*1)+(6*5)+(5*3)+(4*4)+(3*1)+(2*6)+(1*8)=91
91 % 10 = 1
So 15341-68-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H8O4/c1-4-6(7(9)10)2-5(3-8)11-4/h2,8H,3H2,1H3,(H,9,10)

15341-68-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(hydroxymethyl)-2-methylfuran-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 5-(hydroxymethyl)-2-methyl-3-furoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15341-68-1 SDS

15341-68-1Downstream Products

15341-68-1Relevant academic research and scientific papers

PIPERIDINE DERIVATIVES FOR USE IN THE TREATMENT OF PANCREATIC CANCER

-

, (2018/03/01)

The present invention relates to novel piperidine derivatives having better cell growth inhibitory activities toward cancer cell cultures and, more particularly, PANC-1 cancer cell cultures than FK866. Accordingly, the present invention relates to compoun

Discovery and hit-to-lead optimization of novel allosteric glucokinase activators

Lang, Martin,Seifert, Markus H.-J.,Wolf, Kristina K.,Aschenbrenner, Andrea,Baumgartner, Roland,Wieber, Tanja,Trentinaglia, Viola,Blisse, Marcus,Tajima, Nobumitsu,Yamashita, Tokuyuki,Vitt, Daniel,Noda, Hitoshi

supporting information; scheme or table, p. 5417 - 5422 (2011/10/12)

We report on a hit generation and hit-to-lead program of a novel class of glucokinase activators (GKAs). Hit compounds, activators at low glucose concentration only were identified by vHTS. Scaffold modification reliably afforded activators also at high s

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 15341-68-1